The Centers for Disease Control and Prevention (CDC) intends to award a fixed-price contract on a sole source basis to IMS Government Solutions, Fairfax, Virginia for Xponent and National Prescription Audit (NPA) for 2006 through 2014 in order to examine the association between levels of opioid prescribing and injuries associated with illicit drug use behaviors nationally. The IMS Xponent database is currently the only database that collects prescription opioid sales data at the county-level across the entire United States of America from 2006-2013. Alternative sources of prescription drug sales data at the county level across the US were considered; however none of the aforementioned databases currently has the quality, time-span, and depth required by the Government. The North American Industry Classification System Code (NAICS) for this requirement is 518210. This contract action is for supplies and/or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR Part 6.302-1 and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This Notice of Intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the Contract Specialist, Lee Catherine Kennedy, at [email protected] by 10:00am EDT, Thursday, 17 September 2015.

Bid Protests Not Available